跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NEMLUVIO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30MG - HSA Drug Approval Details
Approvals
/
HSA
/
NEMLUVIO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30MG
Approved
THERAPEUTIC
NEMLUVIO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30MG
Vetter Pharma-Fertigung GmbH & Co. KG (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
Mar 17, 2025
Approval ID
e4dd670ec513ab48
Company
Vetter Pharma-Fertigung GmbH & Co. KG (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
e4dd670ec513ab48
Drug Name
NEMLUVIO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30MG
Product Name
NEMLUVIO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30MG
Approval Number
SIN17207P
Approval Date
2025-03-17
Registrant
GALDERMA SINGAPORE PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
SUBCUTANEOUS
Atc Code
D11AH12
Pharma Manufacturer Name
GALDERMA SINGAPORE PRIVATE LIMITED
Active Ingredients
Nemolizumab
30mg
Nemolizumab
30mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 17, 2025
Approval ID
e4dd670ec513ab48
Type
Therapeutic
Back to HSA Approvals